300143 Stock Overview
Focuses on building an ecological platform for chain of pre-diagnosis/treatment/health providing medical services for tumors in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
INKON Life Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥9.40 |
| 52 Week High | CN¥11.39 |
| 52 Week Low | CN¥6.51 |
| Beta | 0.90 |
| 1 Month Change | -6.93% |
| 3 Month Change | 30.37% |
| 1 Year Change | -12.07% |
| 3 Year Change | -33.43% |
| 5 Year Change | 0.86% |
| Change since IPO | -16.75% |
Recent News & Updates
Recent updates
INKON Life Technology Co., Ltd. (SZSE:300143) Looks Just Right With A 26% Price Jump
Sep 30
Returns Are Gaining Momentum At INKON Life Technology (SZSE:300143)
Sep 29INKON Life Technology (SZSE:300143) Seems To Use Debt Quite Sensibly
Sep 10INKON Life Technology Co., Ltd. Just Missed EPS By 16%: Here's What Analysts Think Will Happen Next
Apr 23What You Can Learn From INKON Life Technology Co., Ltd.'s (SZSE:300143) P/S
Mar 28Shareholder Returns
| 300143 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | -3.7% | -2.2% | -1.2% |
| 1Y | -12.1% | -7.7% | 11.8% |
Return vs Industry: 300143 underperformed the CN Healthcare industry which returned -7.7% over the past year.
Return vs Market: 300143 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 300143 volatility | |
|---|---|
| 300143 Average Weekly Movement | 9.6% |
| Healthcare Industry Average Movement | 8.3% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 300143 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300143's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 2,268 | Wen Peng | www.300143.net |
INKON Life Technology Co., Ltd. focuses on building an ecological platform for chain of pre-diagnosis/treatment/health providing medical services for tumors in China and internationally. The company engages in the research, development, innovation, and services of scenarios and equipment medical devices. The company was formerly known as Starmap Medicine and Technology Co., Ltd.
INKON Life Technology Co., Ltd. Fundamentals Summary
| 300143 fundamental statistics | |
|---|---|
| Market cap | CN¥6.97b |
| Earnings (TTM) | CN¥88.93m |
| Revenue (TTM) | CN¥1.60b |
78.4x
P/E Ratio4.4x
P/S RatioIs 300143 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300143 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.60b |
| Cost of Revenue | CN¥1.19b |
| Gross Profit | CN¥407.66m |
| Other Expenses | CN¥318.73m |
| Earnings | CN¥88.93m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.12 |
| Gross Margin | 25.56% |
| Net Profit Margin | 5.58% |
| Debt/Equity Ratio | 21.9% |
How did 300143 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 05:26 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
INKON Life Technology Co., Ltd. is covered by 12 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| YANG QIAO | Changjiang Securities Co. LTD. |
| Junqi Huang | China Merchants Securities Co. Ltd. |
| Dahui Zhao | China Minzu Securities |